TWST logo

Twist Bioscience (TWST) Company Overview

Profile

Full Name:

Twist Bioscience Corporation

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

October 31, 2018

Indexes:

Not included

Website:

http://www.twistbioscience.com

Description:

Twist Bioscience Corp is a company specializing in synthetic biology. It is developing a breakthrough DNA synthesis platform for the industrialization of biological engineering. The company's DNA synthesis platform uses a patented process for producing synthetic DNA based on semiconductors, which synthesizes DNA on silicon rather than on traditional plastic plates with wells, allowing for faster and more affordable production of high-quality synthetic DNA, eliminating inefficiencies and ensuring cost-effectiveness, rapid high-throughput synthesis, enabling researchers to quickly realize opportunities. Geographically, it derives most of its revenue from the United States. The company was founded in 2013 and is headquartered in South San Francisco, California.

Key Details

Price

$41.54

Market Cap

$2.48 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$312.97 M(+27.69% YoY)

Annual EPS

-$3.60(0.00% YoY)

PE Ratio

-

Annual ROE

-38.08%

Annual Debt To Equity

0.00

Beta

2.78

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 3, 2025

Recent annual earnings:

Nov 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 4, 25 Scotiabank
Sector Outperform
Feb 4, 25 JP Morgan
Underweight
Feb 4, 25 Baird
Outperform
Dec 13, 24 Wolfe Research
Outperform
Nov 26, 24 TD Cowen
Buy
Nov 19, 24 Scotiabank
Sector Outperform
Nov 19, 24 Barclays
Overweight
Nov 19, 24 Baird
Outperform
Oct 17, 24 Leerink Partners
Market Perform
Oct 1, 24 Evercore ISI Group
Outperform

Screeners with TWST included

Growing Shares Outstanding
Mid cap stocks
US stocks
Stocks with high beta
Most recommended stocks
Best performing stocks last 5 years
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$41.54
TWST price is $41.54

Price All-time High

$207.97
TWST price is currently -80.03% below its historical high of $207.97

Price Analysts Target

$57.17
TWST price is currently -27.34% lower than the consensus analysts' forecast

Price Most Recent Change

+8.46%
TWST price was up +8.46% on Mar 5, 2025

Price YTD Change

-10.61%
TWST price is down -10.61% since January 1st

Price 3-Year Change

-13.73%
TWST price is down -13.73% over the past 3 years

Market cap

Market Cap

$2.48 B
TWST market capitalization is $2.48 billion

Market Cap 3-Year Change

-8.29%
TWST market capitalization is down -8.29% over the past 3 years

Market Cap All-time High

$10.11 B
TWST market capitalization is currently -75.49% below its historical high of $10.11 billion

Market Cap Sector Rank

83.7%
TWST market capitalization is higher than 83.7% of companies in Healthcare sector

Technical

Beta

2.78
TWST beta is 2.78

200-day SMA

$46.61
TWST price is currently -10.89% below its 200-day simple moving average

14-day RSI

44.05
TWST 14-day relative strength index is 44.05

30-day Relative Volume

1.27
TWST 30-day relative volume is 1.27

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$312.97 M
TWST annual revenue is $312.97 million

Annual Revenue Analysts Estimate

$376.08 M
TWST annual revenue is currently -16.78% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+27.69%
TWST annual revenue is up +27.69% year-on-year

Annual Revenue Sector Rank

70.47%
TWST annual revenue is higher than 70.47% of companies in Healthcare sector

Profit

Annual Gross Profit

$133.35 M
TWST annual gross profit is $133.35 million

Annual Gross Margin

42.61%
TWST annual gross profit margin is 42.61%

Annual Operating Profit

-$175.90 M
TWST annual operating income is -$175.90 million

Annual Operating Margin

-56.20%
TWST annual operating profit margin is -56.20%

Annual Net Income

-$208.73 M
TWST annual net profit is -$208.73 million

Annual Net Margin

-66.69%
TWST annual net profit margin is -66.69%

EPS

Annual EPS

-$3.60
TWST annual earnings per share is -$3.60

Annual EPS Analysts Estimate

-$2.23
TWST annual earnings per share is currently +61.31% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

0%
TWST {parameterFullLabel} has remained unchanged year-on-year

Annual EPS Sector Rank

28.93%
TWST annual earnings per share is higher than 28.93% of companies in Healthcare sector

ROA & ROE

Annual ROA

-30.02%
TWST annual return on assets is -30.02%

Annual ROE

-38.08%
TWST annual return on equity is -38.08%

EBIT & EBITDA

Annual EBIT

-$208.14 M
TWST annual earnings before interest & taxes is -$208.14 million

Annual EBITDA

-$176.71 M
TWST annual EBITDA is -$176.71 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TWST price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TWST price to earnings ratio is unknown

PB Ratio

PB Ratio

5.43
TWST price to book ratio is 5.43

PB Ratio Sector Rank

83.99%
TWST price to book ratio is higher than 83.99% of companies in Healthcare sector

PS Ratio

PS Ratio

7.50
TWST price to sales ratio is 7.50

PS Ratio Sector Rank

71.82%
TWST price to sales ratio is higher than 71.82% of companies in Healthcare sector

Enterprise value

Enterprise Value

$2.34 B
TWST enterprise value is $2.34 billion

Enterprise Value Sector Rank

82.68%
TWST enterprise value is higher than 82.68% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-14.00
TWST EV/EBITDA is -14.00

EV/EBITDA Sector Rank

9.46%
TWST EV/EBITDA is higher than 9.46% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.88
TWST annual current ratio is 4.88

Annual Quick Ratio

4.54
TWST annual quick ratio is 4.54

Leverage

Annual Debt To Equity

0.00
TWST annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-7177.14
TWST annual interest coverage ratio is -7177.14

Risk & Stability

Piotroski F-Score

4
TWST piotroski f-score is 4

Altman Z-Score

7.60
TWST altman z-score is 7.60

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$614.32 M
TWST annual total assets is $614.32 million

Annual Non Current Assets

$267.55 M
TWST annual long term assets is $267.55 million

Annual Current Assets

$346.78 M
TWST annual total current assets is $346.78 million

Annual Cash & Cash Equivalents

$226.32 M
TWST annual cash & cash equivalents is $226.32 million

Equity

Annual Book Value

$472.69 M
TWST annual book value is $472.69 million

Annual Working Capital

$275.77 M
TWST annual working capital is $275.77 million

Liabilities

Annual Total Liabilities

$141.63 M
TWST annual total liabilities is $141.63 million

Annual Total Long Term Liabilities

$70.63 M
TWST annual total long term liabilities is $70.63 million

Annual Current Liabilities

$71.01 M
TWST annual total current liabilities is $71.01 million

Annual Accounts Payable

$1.63 M
TWST annual accounts payable is $1.63 million

Debt

Annual Total Debt

$85.03 M
TWST annual total debt is $85.03 million

Annual Total Debt 1-Year Change

-9.61%
TWST annual total debt is down -9.61% year-on-year

Annual Long Term Debt

$70.22 M
TWST annual long term debt is $70.22 million

Annual Short Term Debt

$14.80 M
TWST annual short term debt is $14.80 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$488.88 M
TWST annual total expenses is $488.88 million

Annual Operating Expenses

$309.25 M
TWST annual total operating expenses is $309.25 million

Annual Cost Of Goods Sold

$179.63 M
TWST annual cost of goods sold is $179.63 million

Annual SGA

$218.40 M
TWST annual SGA is $218.40 million

Annual D&A

$31.43 M
TWST annual depreciation & amortization is $31.43 million

Annual Interest Expense

$29.00 K
TWST annual interest expense is $29.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$64.09 M
TWST annual cash flow from operations is -$64.09 million

Annual CFO 1-Year Change

+55.01%
TWST annual cash flow from operations is up +55.01% year-on-year

Annual CFI

-$3.07 M
TWST annual cash flow from investing activities is -$3.07 million

Annual CFI 1-Year Change

-106.07%
TWST annual cash flow from investing activities is down -106.07% year-on-year

Annual CFF

$6.89 M
TWST annual cash flow from financing activities is $6.89 million

Annual CFF 1-Year Change

+656.31%
TWST annual cash flow from financing activities is up +656.31% year-on-year

Free CashFlow

Annual FCF

-$69.17 M
TWST annual free cash flow is -$69.17 million

Annual FCF 1-Year Change

+59.37%
TWST annual free cash flow is up +59.37% year-on-year

CAPEX

Annual CAPEX

$5.08 M
TWST annual capital expenditures is $5.08 million

Annual CAPEX 1-Year Change

-81.73%
TWST annual capital expenditures is down -81.73% year-on-year

Institutional Ownership

Similar stocks

NAMS logo
NewAmsterdam Pharma Company NV (NAMS)
EWTX logo
Edgewise Therapeutics (EWTX)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
VCYT logo
Veracyte (VCYT)
VCEL logo
Vericel (VCEL)
PTGX logo
Protagonist Therapeutics (PTGX)
Rapport Therapeutics (RAPP)
DNLI logo
Denali Therapeutics (DNLI)
SEM logo
Select Medical Holdings (SEM)

FAQ

  • What is the ticker symbol for Twist Bioscience?
  • Does Twist Bioscience pay dividends?
  • What sector is Twist Bioscience in?
  • What industry is Twist Bioscience in?
  • What country is Twist Bioscience based in?
  • When did Twist Bioscience go public?
  • Is Twist Bioscience in the S&P 500?
  • Is Twist Bioscience in the NASDAQ 100?
  • Is Twist Bioscience in the Dow Jones?
  • When was Twist Bioscience's last earnings report?
  • When does Twist Bioscience report earnings?
  • Should I buy Twist Bioscience stock now?

What is the ticker symbol for Twist Bioscience?

The ticker symbol for Twist Bioscience is NASDAQ:TWST

Does Twist Bioscience pay dividends?

No, Twist Bioscience does not pay dividends

What sector is Twist Bioscience in?

Twist Bioscience is in the Healthcare sector

What industry is Twist Bioscience in?

Twist Bioscience is in the Diagnostics & Research industry

What country is Twist Bioscience based in?

Twist Bioscience is headquartered in United States

When did Twist Bioscience go public?

Twist Bioscience's initial public offering (IPO) was on October 31, 2018

Is Twist Bioscience in the S&P 500?

No, Twist Bioscience is not included in the S&P 500 index

Is Twist Bioscience in the NASDAQ 100?

No, Twist Bioscience is not included in the NASDAQ 100 index

Is Twist Bioscience in the Dow Jones?

No, Twist Bioscience is not included in the Dow Jones index

When was Twist Bioscience's last earnings report?

Twist Bioscience's most recent earnings report was on Feb 3, 2025

When does Twist Bioscience report earnings?

The next expected earnings date for Twist Bioscience is May 2, 2025

Should I buy Twist Bioscience stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions